[Effect of remifentanil preconditioning on myocardial ischemia-reperfusion injury]. 2009

Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
Department of Anesthesiology, Cancer Hospital and Institute, CAMS and PUMC, Beijing 100021, China.

OBJECTIVE To investigate the delayed cardioprotection induced by remifentanil in intact rat ischemia-reperfusion (I/R) models. METHODS Totally 42 adult male Wistar rats weighing 200-300 g were randomly divided into 7 groups (n = 6 in each group): In Group I, rats were injected with normal saline via tail vein, performed with the regimen of 3 x 5-min intravenous (i.v.) infusion at a rate of 0.1 ml x kg(-1) min(-1) 24 h before I/R; In Group II, rats were treated according to the same experimental protocols as in Group I except receiving additional naloxone (0.1 mg/kg) 10 minutes before normal saline pretreatment; In Groups III, IV, V, and VI, rats were treated with remifentanil via tail vein, performed with the regime of 3 x 5-min i.v. infusion at a rate of 2 microg x kg(-1) x min(-1) 12 h, 24 h, 48 h, and 72 h before I/R; In Group VII, the rats were treated according to the same experimental protocols as in Group IV except that they received additional naloxone (0.1 mg/kg) 10 minutes before remifentanil pretreatment. Heart rate (HR), mean arterial pressure (MAP), and a lead II electrocardiogram were continuously monitored during IR process. To determine plasma concentration of creatine kinase myocardial isoenzyme-MB (CK-MB), arterial blood samples were obtained immediately before ischemia, and at the end of ischemia and reperfusion. After a 120-min reperfusion, heart was removed for the measurement of myocardial infarct size. Infarct size (IS) was expressed as percentage of the area at risk. RESULTS HR, MAP, and rate-pressure product were not significantly different at each time points among all groups (P > 0.05). Compared with Group I, plasma concentrations of CK-MB at the end of ischemia and reperfusion and myocardial infarct size were significantly lower in Groups IV and V (P < 0.05). Compared with Group IV, plasma concentrations of CK-MB at the end of ischemia and reperfusion were significantly higher and myocardial infarct size was significantly larger in Group VII (P < 0.05). CONCLUSIONS Remifentanil preconditioning induces delayed cardioprotection in intact rat ischemia-reperfusion model, which may be triggered via opioid receptors.

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000077208 Remifentanil A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care. 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester,GI 87084B,GI-87084B,GI87084B,Remifentanil Hydrochloride,Remifentanil Monohydrochloride,Ultiva
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019157 Ischemic Preconditioning, Myocardial Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes. Myocardial Preconditioning,Myocardial Ischemic Preconditioning,Preconditioning, Myocardial,Preconditioning, Myocardial Ischemic

Related Publications

Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
February 2008, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
January 2018, Bratislavske lekarske listy,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
December 2009, Transplantation proceedings,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
July 2019, European review for medical and pharmacological sciences,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
April 2010, The Journal of surgical research,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
May 2021, Bioscience reports,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
August 2000, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
January 2012, International braz j urol : official journal of the Brazilian Society of Urology,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
September 2018, Zhonghua xin xue guan bing za zhi,
Hai-Tao Sun, and Fu-Shan Xue, and Kun-Peng Liu, and Li Sun, and Ya-Chao Xu, and Xu Liao, and Quan-Yong Yang, and Yan-Ming Zhang
May 2013, Experimental and therapeutic medicine,
Copied contents to your clipboard!